Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 4Prostatic Neoplasms 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Neoplasms 3Urinary Bladder Neoplasms 2Rectal Neoplasms 2Hematologic Neoplasms 2Colorectal Neoplasms 2Anatomic Stage I Breast Cancer AJCC v8 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stomatitis 1Stomach Neoplasms 1Sarcoma 1Recurrence 1Radiodermatitis 1Papillomavirus Infections 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Multiple Endocrine Neoplasia Type 1 1Melanoma 1Lung Neoplasms 1Localized Prostate Carcinoma 1Leukemia, Myeloid, Acute 1Hepatitis B 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Endometrial Clear Cell Adenocarcinoma 1Disease Progression 1

Interventions

Carboplatin 23Cisplatin 19pembrolizumab 14Paclitaxel 12Gemcitabine 12Pemetrexed 11130-nm albumin-bound paclitaxel 9Everolimus 8Cetuximab 8Fluorouracil 7Axitinib 6osimertinib 5durvalumab 5Sunitinib 5Radiotherapy 5Erlotinib Hydrochloride 5Docetaxel 5Cyclophosphamide 5Albumin-Bound Paclitaxel 5Sorafenib 4Radiation 4Nivolumab 4Ipilimumab 4vosaroxin 3Radiotherapy, Intensity-Modulated 3Octreotide 3Irinotecan 3Bevacizumab 31-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 3pralsetinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Carcinoma × Practice Guidelines as Topic × Clear all
NCT03857620 2026-04-30

Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer

Alliance for Clinical Trials in Oncology

Phase NA Active not recruiting
325 enrolled 14 charts
Tumor-Agnostic

Carcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡